HuagongsheHuagongshe Chemistry Print Report · For research reference only
Imidazole → 3beta-(Tert.-butyldimethylsilyloxy)-7beta-hydroxy-15beta,16beta-methylene-5-androsten-17-one
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Imidazole | HCID 795 | — |
| Reactant | tert-Butyldimethylsilyl chloride | HCID 28928 | — |
| Reactant | 3beta,7beta-Dihydroxy-15beta,16beta-methylene-5-androsten-17-one | HCID 44520204 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | 3beta-(Tert.-butyldimethylsilyloxy)-7beta-hydroxy-15beta,16beta-methylene-5-androsten-17-one | HCID 70467159 | 78.9% |
Reaction Conditions
| Temperature | -20 °C |
|---|
Reaction Steps
A solution of 120 g of 3β,7β-dihydroxy-15β,16β-methylene-5-androsten-17-one in 1,000 ml of dimethylformamide is combined with 31 g of imidazole and cooled to -20° C. Within 2 hours, 63 g of tert.-butyldimethylchlorosilane in 450 ml of dimethylformamide is added dropwise to the reaction mixture, and the latter is agitated for another hour. The reaction product is precipitated with sodium-chloride-containing water, filtered off, washed with water, and dissolved in methylene chloride. The solution is dried over sodium sulfate and evaporated. After chromatography on silica gel with hexane-acetone, 128.8 g of 3β-(tert.-butyldimethylsilyloxy)-7β-hydroxy-15β,16β-methylene-5-androsten-17-one is obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US04416985 |
| Source dataset | uspto-grants-1983_11 |
| ORD ID | ord-7ed0c613d60e4261b78a68155568e714 |
| Source note | uspto-grants-1983_11 |